Learn More
Selleck Chemical LLC Dactolisib (BEZ235) 50mg 915019-65-7 NVP-BEZ235

Supplier: Selleck Chemical LLC S100950MG
Dactolisib (BEZ235, NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor for¿p110?/?/?/?¿and mTOR(p70S6K)¿with¿IC50¿of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits¿ATR¿with¿IC50¿of 21 nM in 3T3TopBP1-ER cell. Dactolisib induces autophagy and suppresses HIV-1 replication. Phase 2. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.